The finding is expected to allow researchers to develop a simple blood test within five years to be used in conjunction with a breast screening to help pinpoint specific genes associated with breast cancer.
The city raised $7,000 during 2015 and 2016 each, which went to the Sisters Network of Central New Jersey, Bradshaw said.
Now, a new study in the journal "Oncotarget" may give a hint as to why some seemingly healthy, normal women get breast cancer.
"We knew about 100 before, it is a big contribution but probably more important than the number is the methods we developed", she said.
Sources of funding include grants from pharmaceutical companies, 5K walks and donations such as the one from the fire department, Reed said, and a large portion of that money comes from fundraising efforts through October. The World Health Organisation suggests breast cancer as one of the leading causes of mortality in women, especially in developing countries where most cases are detected in the later stages.
"Our group was formed to help underserved women in the community", Reed said.
The city is now looking at where to donate this year's proceeds, Bradshaw said, and is considering the Sisters Network, among different local breast cancer support organizations.
"This ultimately could benefit all women - in those with a strong family history and those without", an Australian researcher involved with the study, Professor Georgia Chenevix-Trench, told The New Daily.
After studying 122,977 cases of ER-positive cases, researchers can explain an additional 4 percent of that heritable breast cancer risk.
"As well as identifying new genetic variants, we have also confirmed many that we had previously suspected". However, we have developed a mathematical algorithm that incorporates the effect of each of the variations worn by a woman and which calculates from this the probability of her developing breast cancer, " says Simard, who sees in this new tool a way to identify women without a family history of breast cancer or ovarian cancer, but who are at high risk of suffering from such a cancer.
"I had genetic testing and I was negative for all the genetic testing", Moeller said.
The additions almost double the number of genetic markers known to scientists, providing a trove of data for future studies to investigate in search of better understanding, new detection methods, and potentially more effective treatments.
Mutations in these genes prevent them from repairing changes in other sections of DNA in breast tissue, raising the risk of further mutation.